- Home
- MTW vs HUMA Comparison
MTW vs HUMA Comparison
Compare MTW & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTW
- HUMA
- Stock Information
- Founded
- MTW 1902
- HUMA 2004
- Country
- MTW United States
- HUMA United States
- Employees
- MTW N/A
- HUMA N/A
- Industry
- MTW Construction/Ag Equipment/Trucks
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- MTW Industrials
- HUMA Health Care
- Exchange
- MTW Nasdaq
- HUMA Nasdaq
- Market Cap
- MTW 358.5M
- HUMA 250.2M
- IPO Year
- MTW N/A
- HUMA N/A
- Fundamental
- Price
- MTW $9.89
- HUMA $1.51
- Analyst Decision
- MTW Hold
- HUMA Strong Buy
- Analyst Count
- MTW 4
- HUMA 8
- Target Price
- MTW $11.00
- HUMA $10.88
- AVG Volume (30 Days)
- MTW 381.2K
- HUMA 5.9M
- Earning Date
- MTW 08-07-2025
- HUMA 08-11-2025
- Dividend Yield
- MTW N/A
- HUMA N/A
- EPS Growth
- MTW 436.41
- HUMA N/A
- EPS
- MTW 1.26
- HUMA N/A
- Revenue
- MTW $2,131,200,000.00
- HUMA $818,000.00
- Revenue This Year
- MTW N/A
- HUMA N/A
- Revenue Next Year
- MTW $4.66
- HUMA $949.92
- P/E Ratio
- MTW $7.86
- HUMA N/A
- Revenue Growth
- MTW N/A
- HUMA N/A
- 52 Week Low
- MTW $7.06
- HUMA $1.15
- 52 Week High
- MTW $13.62
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- MTW 38.48
- HUMA 36.87
- Support Level
- MTW $9.91
- HUMA $1.43
- Resistance Level
- MTW $10.19
- HUMA $1.67
- Average True Range (ATR)
- MTW 0.35
- HUMA 0.15
- MACD
- MTW 0.08
- HUMA -0.01
- Stochastic Oscillator
- MTW 61.07
- HUMA 23.32
About MTW Manitowoc Company Inc. (The)
Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.